The prevalence of gastric ulceration in racehorses in New Zealand

Bell, Robin J.; Kingston, Janene K.; Mogg, T D; Perkins, N. R.

doi:10.1080/00480169.2007.36729

Cited by 70 publications

(63 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The horses selected for the study were representative of the typical population affected by EGUS, i.e., high concentrates fed horses in training. Localisation, number and severityof the gastric lesions observed were consistent with previous studies (Ferrucci et al, 2003a;Roy et al, 2005;Bell et al,2007;Tamzali et al, 2011).…”

Section: Discussionsupporting

confidence: 80%

“…Equine Gastric Ulcer Syndrome (EGUS) is one of the most common causes of poor performance in the equine patient and affects more than 90% of Standardbred and Thoroughbred racehorses in training (Ferrucci et al, 2003a;Roy et al, 2005;Bell et al, 2007). EGUS also affects horses involved in others disciplines such as endurance (Tamzali et al, 2011), show horses (White et al, 2007) and horses not involved in competition, such as broodmares (Le Jeune et al, 2009).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy of the Administration of a Natural Feed Supplement in the Management of Equine Gastric Ulcer Syndrome in 7 Sport Horses: A Field Trial

Stucchi¹,

Zucca²,

Alessia³

et al. 2017

American Journal of Animal and Veterinary Sciences

View full text Add to dashboard Cite

Equine Gastric Ulcer Syndrome (EGUS) is one of the most common causes of poor performance in the equine patient and affects more than 90% of Standardbred and Thoroughbred racehorses in training. Nowadays, the principal therapeutic options for EGUS treatment include antiacids such as histamine receptor antagonists and proton pump inhibitors. Recently, many studies concerning feed supplements to treat and prevent EGUS were carried out. The aim of the present study was to evaluate the efficacy of a natural feed supplement, administered for 30 days, as the only treatment for gastric ulcerations in sport horses in training. Seven horses were selected for the study on the basis of their gastroscopic evidence of erosive and ulcerative lesions of the gastric mucosa. Each horse received a natural feed supplement (Gastrocure, Institute Farmaceutico Candioli, Italy) registered for use in horses for 30 days. Gastroscopy was performed on day 0 (T 1 ), day 15 (T 2 ) and at the end of the treatment (day 30, T 3 ). Scores were assigned according to MacAllister method (score 0,1,2,3,4 for number of lesions and score 0,1,2,3,4,5 for lesion severity). Statistical analysis showed a strong evidence (p<0.01) of lower scores occurring at T 3 when compared to T1for both number and severity of gastric lesions. In conclusion, the administration of Gastrocure was effective in reducing the number and severity of ulcerative lesions in horses affected by EGUS.

show abstract

Section: Discussionsupporting

confidence: 80%

Section: Introductionmentioning

confidence: 99%

Efficacy of the Administration of a Natural Feed Supplement in the Management of Equine Gastric Ulcer Syndrome in 7 Sport Horses: A Field Trial

Stucchi¹,

Zucca²,

Alessia³

et al. 2017

American Journal of Animal and Veterinary Sciences

View full text Add to dashboard Cite

show abstract

“…Horses with access to some turnout were less likely to have ESGD, and this risk was even lower if they were turned out with other horses in one study of Thoroughbred racehorses in training 23. Conversely no effect of quality of pasture, or time at pasture (stabled, stable and pasture, pastured) was shown on ESGD prevalence in another study of Thoroughbred racehorses 25. In addition, there were no differences observed on intragastric pH in horses fed ad libitum grass hay and grain twice a day (1 kg/100 kg/d) when they were housed in a grass paddock, in a stall on their own or in a stall with an adjacent companion, suggesting that pasture turnout on its own might not affect gastric pH per se 26…”

Section: Epidemiologymentioning

confidence: 84%

“…However, this relationship might not be linear or temporally consistent and there is currently a paucity of information in the literature demonstrating a direct cause‐and‐effect relationship between clinical signs and the presence, severity, or location of gastric ulcers in adult horses. Furthermore, we know that many horses with EGUS will not demonstrate clinical signs, and are considered to have ‘silent’ or non‐clinical gastric ulceration 14, 25, 33. Whether these horses are truly without clinical signs, or simply subclinical, warrants consideration as there is improved behavior after treatment in some patients 33…”

Section: Ulcer Gradingmentioning

confidence: 99%

European College of Equine Internal Medicine Consensus Statement—Equine Gastric Ulcer Syndrome in Adult Horses

Sykes

Hewetson

Hepburn³

et al. 2015

Veterinary Internal Medicne

228

436

View full text Add to dashboard Cite

“…The prevalence of squamous ulceration in racing Thoroughbreds has been reported as >70% in several studies [1][2][3][4][5][6][7][8][9]. Equine gastric ulcer syndrome (EGUS) is detrimental to horse health and performance due to associated pain and discomfort, [10,11].…”

Section: Introductionmentioning

confidence: 99%

A Comparison Between Omeprazole and a Dietary Supplement for the Management of Squamous Gastric Ulceration in Horses

Kerbyson

Knottenbelt

Carslake

et al. 2016

Journal of Equine Veterinary Science

View full text Add to dashboard Cite

Although several studies have assessed the short-term effect of dietary supplements on the treatment and prevention of gastric ulceration in horses, few have assessed the response over a duration of more than 30 days. 2A blinded randomised non-inferiority clinical trial was conducted using forty-two Thoroughbred horses in race training with squamous ulceration of ≥ grade 2/4, randomly assigned to one of two treatment groups for a period of 90 days: omeprazole at the full label dose of 4mg/kg or the Succeed® digestive conditioning supplement. Non-inferiority analyses and Wilcoxon sign rank tests were used to analyse the data.At day 90, Succeed® was non-inferior to 4mg/kg omeprazole administered daily in terms of the proportion of horses with complete resolution of squamous ulceration.At day 30, Succeed® was found to be inferior to omeprazole in terms of the proportion of horses with grade ≤1/4 squamous ulceration. The proportion of horses with reducing squamous ulcer score (compared with day 0) was statistically significant for both treatments at days 30 and 60. At day 90 of the 17 horses on Succeed®, nine had a reducing squamous ulcer score (p-value = 0.049) and of the 19 horses on omeprazole, 10 had a reducing squamous ulcer score at day 90 (p-value = 0.091).The non-inferiority of Succeed® compared to omeprazole at 90 days for the complete resolution of squamous ulceration and the reduced efficacy of omeprazole following 90 days of treatment are likely to be of interest to practitioners managing gastric ulceration in performance horses.

show abstract

The prevalence of gastric ulceration in racehorses in New Zealand

Abstract: The prevalence of gastric ulceration in racehorses in New Zealand is similar to that reported elsewhere for horses in active training for racing. Access to pasture for some or all of the day did not appear to be protective.

Cited by 70 publications

References 28 publications

Efficacy of the Administration of a Natural Feed Supplement in the Management of Equine Gastric Ulcer Syndrome in 7 Sport Horses: A Field Trial

Efficacy of the Administration of a Natural Feed Supplement in the Management of Equine Gastric Ulcer Syndrome in 7 Sport Horses: A Field Trial

European College of Equine Internal Medicine Consensus Statement—Equine Gastric Ulcer Syndrome in Adult Horses

A Comparison Between Omeprazole and a Dietary Supplement for the Management of Squamous Gastric Ulceration in Horses

Contact Info

Product

Resources

About